Isotiorga

Isotretinoin, the active ingredient in Isotiorga, is a retinoid presented as an oral formulation for oral use. It is indicated for the treatment of severe recalcitrant nodular acne in patients who have not responded to conventional therapies.

GNH USA supplies Isotiorga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution. The company ensures batch traceability, regulatory compliance, and timely delivery to meet the needs of healthcare providers across multiple regions.

Isotiorga (isotretinoin) is a retinoid used in dermatology to manage severe acne. - Severe recalcitrant nodular acne: reduces lesion count and promotes long‑term remission. - Severe inflammatory acne: decreases inflammation and sebum production. - Severe cystic acne: helps prevent new cyst formation and scarring.

Isotiorga may cause a range of adverse reactions.

Common Side Effects: - Dry skin: excessive dryness and scaling. - Cheilitis: cracking and inflammation of the lips. - Dry eyes: irritation and reduced tear production. - Nasal mucosal dryness: leading to nosebleeds. - Photosensitivity: increased sensitivity to sunlight. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Elevated liver enzymes: indicating potential hepatic injury. - Hypertriglyceridemia: significant rise in blood triglyceride levels. - Depression or suicidal thoughts: mood changes requiring immediate evaluation. - Pseudotumor cerebri: increased intracranial pressure presenting with headaches and visual disturbances. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Teratogenicity: risk of birth defects if exposure occurs during pregnancy.

Before initiating therapy, several safety considerations are essential. - Pregnancy contraindication: avoid use in pregnant women; ensure effective contraception. - Contraception requirement: use two reliable methods throughout treatment and for one month after discontinuation. - Liver function monitoring: assess hepatic enzymes periodically. - Lipid profile monitoring: check triglyceride levels during therapy. - Vitamin A supplementation avoidance: do not combine with other retinoids or high‑dose vitamin A. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and light.

Isotiorga can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Tetracycline antibiotics: reduced isotretinoin effectiveness. - Vitamin A supplements: increased risk of toxicity. - Systemic corticosteroids: heightened chance of pseudotumor cerebri. - Phenobarbital: may lower isotretinoin plasma levels. - Oral contraceptives: possible reduction in contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Other oral retinoids: additive teratogenic risk. - Azithromycin: monitor for liver enzyme changes. - Hepatotoxic drugs (e.g., methotrexate): watch liver function tests. - Lipid‑altering agents: observe triglyceride levels.